Inherited susceptibility to breast and ovarian cancer

Current Opinion in Obstetrics and Gynecology

Volumn 10, Issue 1, 1998, Pages 3-8

  Diamond, Theresa M ^a   Sutphen, Rebecca ^a   Tabano, Maggi ^a   Fiorica, James ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ADULT; BREAST CARCINOMA; CANCER SCREENING; CANCER SUSCEPTIBILITY; CASE REPORT; COLORECTAL CANCER; COWDEN SYNDROME; DNA DETERMINATION; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; INFORMED CONSENT; OVARIECTOMY; OVARY CARCINOMA; PRIORITY JOURNAL; REVIEW;

BRCA2 PROTEIN; BREAST NEOPLASMS; DISEASE SUSCEPTIBILITY; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENETIC MARKERS; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PEDIGREE; TRANSCRIPTION FACTORS;

EID: 0031952037     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199802000-00002     Document Type: Review

References (24)

1. American Cancer Society. In: Cancer facts and figures. Atlanta: American Cancer Society; 1997.
2. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stoper J, Campeau L, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336:1409-1415. Reports the results of DNA analysis of BRCA1 from 263 women with breast cancer seen at several breast cancer clinics that represent a more 'typical' population of women requesting information for inherited breast cancer susceptibility. The data were used to calculate the probability of detecting BRCA1 mutations based on average age of diagnosis in the family, presence of ovarian cancer, both breast and ovarian cancer in a family member, and whether the family is of Ashkenazi Jewish descent. The BRCA1 analysis was performed by conformation-sensitive gel electrophoresis.
3. Lerman C, Seay J, Balshem A, Audrain. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995; 57:385-392.
4. Rebbeck TR, Couch FJ, Kant J, Calsone K, DeShano M, Peng Y, et al. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 1996; 59:547-553.
5. Burke W, Daly M, Garber J, Botkin J, Kahn MJE, Lynch P, et al., for the Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2. JAMA 1997; 227:997-1003. This landmark manuscript provides a retrospective analysis of cancer risk, surveillance and risk reduction in persons with an inherited susceptibility to breast and ovarian cancer and provides provisional recommendations for follow-up care for BRCA1 and BRCA2 mutation carriers and their at-risk relatives. This article addresses the need for research protocols to determine the long-term outcome of mutation carriers, efficacy of surveillance methods and prevention strategies to provide sound data for future recommendations for individuals with inherited cancer risk.
6. Struewing JP, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336:1401-1408. Reports the results of 5318 Jewish persons who were tested for the three founder mutations in BRCA1 and BRCA2 in the Ashkenazim and the estimated breast and ovarian cancer risk associated with mutation carriers. The data are based on self-administered questionnaires completed by the subjects; however, cancer histories were not verified by medical records.
7. Gayther S, Mangion J, Russell P, Seal S, Barfoot R, Ponder BAJ, et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature Genet 1997; 15:103-105. Reports the mutation distribution in BRCA2 from 25 families with multiple cases of breast and/or ovarian cancer and indicates a significant genotypephenotype correlation.
8. Shattuck-Eidens D, Oliphant A, McClure M, McBride D, Gupte J, Rubano T, et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations; risk factor analysis and implications for genetic testing. JAMA 1997; 278:1242-1250. This paper gives the results of complete sequence analysis of BRCA1 of 798 persons and provides a method for evaluating the probability of a woman carrying a deleterious BRCA1 mutation to assist clinicians in providing cancer risk assessment.
9. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995; 273:577-585.
10. Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM, et al. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nature Genet 1997; 15:87-90.
11. Liaw D, Marsh J, Li J, Dahia PLM, Wang SI, Zheng Z, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 1997; 16:64-67. This manuscript reports the identification of the putative gene, PTEN, responsible for some individuals and families with Cowden disease, an underdiagnosed breast cancer susceptibility syndrome characterized by multiple benign tumors of the breast, thyroid and skin.
12. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268:1749-1753.
13. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272:1668-1671.
14. Biesecker BB, Boehnke M, Calsone K, Markel DS, Garber JE, Collins FS, Weber BL. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993; 269:1970-1974.
15. Claus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994; 73:643-651.
16. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81:1879-1886
17. Kuska B. Researchers expand genetic epidemiology of BRCA genes. J Natl Cancer Inst 1997; 89:844-845.
18. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 1996; 14:1730-1736. This policy statement provides recommendations for clinical oncologists to responsibly and accurately provide cancer risk assessment, counseling, testing and follow-up for individuals and families with inherited cancer susceptibility. This statement establishes the impact that cancer genetics will have in clinical oncology and the need to provide continuing education in this area for practitioners in clinical oncology.
19. Frank TD, Manley S, Thomas A, McClure M, Ward B, Shattuck-Eidens D, et al. BRCA1 and BRCA2 sequence analysis of 335 high-risk women [abstract]. Am J Hum Genet 1997; 56:A65.
20. Shattuck-Eidens D, McClure M, Simar J, Labrie F, Narod S, Couch F, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 1995; 273:535-541.
21. McKinnon WC, Baty BJ, Bennett RL, Magee M, Neufeld-Kaiser WA, Peters KF, et al. Predisposition genetic testing for late-onset disorder in adults: a position paper of the National Society of Genetic Counselors. JAMA 1997; 278:1217-1220. This paper provides clinicians with information regarding the complexity of genetic testing for adult-onset disorders and recommends the information content that should be included in pre-test education and genetic counseling and post-test counseling and follow-up care.
22. Holtzman NA, Watson MS, Bar PA et al. The Task Force on Genetic Testing: promoting safe and effective genetic testing in the United States: principles and recommendations. Available at: http:// ww2.med.jhu.edu/tfgtelsi
23. Hartmann L, Jenkins R, Schaid D, Tang P. Prophylactic mastectomy (PM): preliminary retrospective cohort analysis [abstract]. Proc Am Assoc Cancer Res 1997; ii:168.
24. Sikorski R, Peters R. Genomic medicine: Internet resources for medical genetics. JAMA 1997; 278:1212-1213.